ImportRefusal LogoImportRefusal

GLAXOSMITHKLINE

⚠️ Moderate Risk

FEI: 3022662322 • Philadelphia, PA • UNITED STATES

FEI

FEI Number

3022662322

📍

Location

Philadelphia, PA

🇺🇸
🏢

Address

2929 Walnut St Fl 1, , Philadelphia, PA, United States

Moderate Risk

FDA Import Risk Assessment

48.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
4
Unique Violations
11/1/2024
Latest Refusal
6/27/2024
Earliest Refusal

Score Breakdown

Violation Severity
66.0×40%
Refusal Volume
17.7×30%
Recency
76.1×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

38961×

NOCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act because it appears to be a nonprescription drug that is misbranded within the meaning of Section 502(x) of the FD&C Act in that the product label fails to bear a domestic address or phone number through which the responsible person may receive a report of a serious adverse event with such drug.

Refusal History

DateProductViolationsDivision
11/1/2024
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
3280FRNMFGREG
3896NOCONTACT
75UNAPPROVED
Division of Northern Border Imports (DNBI)
6/27/2024
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is GLAXOSMITHKLINE's FDA import refusal history?

GLAXOSMITHKLINE (FEI: 3022662322) has 2 FDA import refusal record(s) in our database, spanning from 6/27/2024 to 11/1/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GLAXOSMITHKLINE's FEI number is 3022662322.

What types of violations has GLAXOSMITHKLINE received?

GLAXOSMITHKLINE has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GLAXOSMITHKLINE come from?

All FDA import refusal data for GLAXOSMITHKLINE is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.